Target intelligence / Profile preview

Host immune system pathways

Molecular classification
Other
01

Overview

Host immune system pathways represent the integrated network of biological processes and signaling cascades that protect an organism from pathogenic infections and cellular abnormalities such as cancer. These pathways are broadly categorized into innate immunity, providing rapid and non-specific responses, and adaptive immunity, which offers highly specific and long-term memory-based protection. Key molecular events include the recognition of pathogen-associated molecular patterns (PAMPs), the secretion of cytokines and chemokines, and the activation of specialized cells like lymphocytes and myeloid cells. Dysregulation of these pathways is a primary driver of autoimmune disorders, chronic inflammatory diseases, and the failure of immunosurveillance in oncology. Therapeutic strategies frequently target specific nodes within these pathways—such as TNF-alpha, JAK/STAT signaling, or PD-1/PD-L1 checkpoints—to either dampen pathological inflammation or enhance the body's ability to eliminate tumors and pathogens.

Other names
Immune system signalingHost defense pathwaysImmune response pathwaysImmunological pathways
02

Mechanism of action

Drugs targeting these pathways act through diverse mechanisms including cytokine neutralization, immune checkpoint inhibition, immunosuppression of T-cell activation, and modulation of inflammatory signaling cascades.

03

Biological functions

Immune responseSignal transductionInflammationApoptosisCell proliferationAntigen processing and presentation
04

Disease associations

InfectionCancerAutoimmune diseaseInflammationAllergy
05

Safety considerations

Increased risk of opportunistic infectionsCytokine release syndrome (CRS)Immune-related adverse events (irAEs)Secondary malignanciesHypersensitivity reactions
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)CD4+/CD8+ T-cell ratiosAbsolute neutrophil count

Beyond the preview

Go deeper on Host immune system pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host immune system pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call